Biotech Insights - Presentation of the German Biotechnology Report 2025

How can German biotechnology realize its full potential? This year's German Biotechnology Report 2025, a collaboration between Ernst & Young (EY) and BIO Deutschland eV, addresses this central question. Discover the latest findings and trends shaping the future of biotechnology in Germany. This year's edition of the EY Biotech Report offers an in-depth analysis of the sector's development, challenges, and opportunities, as well as a comprehensive review of investments, international benchmarks, and strategic recommendations. This year's focus is on illuminating the strengths and potential of German biotechnology from various perspectives. This includes aspects such as the role of strategic partnerships, strategies for resilience and innovation in times of geopolitical tension, and how biotechnology is revolutionizing the food industry.

Join Dr. Julia Schüler (BIO. ASPEKT) as she presents figures, data, and facts from the EY Biotech Report and look forward to insights into EY's life science offerings as well as insights from the fields of cell and gene therapy and animal-free antibodies.

We look forward to your participation

Your BioRegioN

Link to dial in via Zoom:

PROGRAM 4:00 PM – 4:05 PM WELCOME

Dr. Yvonne Reinke | BioRegioN, Lower Saxony.next GmbH

4:05 PM – 4:20 PM INSIGHTS: EY Services in Life SciencesKlaus Ort | Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft

4:20 – 4:40 PM PRESENTATION: German Biotechnology Report 2025 Dr. Julia Schüler | BIO. ASPECTS

4:40 – 4:55 PM IMPULSE: Bring back life into breathing Dr. Phillipe Vollmer Barbosa | iGUARD

4:55 PM – 5:10 PM IMPULSE: Antibodies made green Stephanie Pfeil-Coenen | Phaeosynt GmbH

5:15 PM SUMMARY and END